ZZZhuo Zheng

Zhuo Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhuo Zheng has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and Validation of a Mixture-of-Experts–Based Model for Postoperative In-Hospital Mortality Risk Assessment: Multicenter Retrospective Study

    by Shixin Huang, Jinhong Xia, Xixi Nie, Zhuo Zheng, Jiawei Luo

    Background: Postoperative mortality remains a key indicator of surgical safety and quality. Traditional risk models based on static preoperative or intraoperative variables often fail to capture dynamic physiological changes during surgery and generalize poorly across surgical types. To address these limitations, we developed and validated a deep learning framework capable of learning heterogeneous temporal patterns from intraoperative signals while maintaining interpretability and adaptability. Objective: This study aimed to develop a mixture-of-experts–based model (Postoperative Risk Modeling Expert network, PRIME-MoE) to provide dynamic, surgery-adaptive postoperative in-hospital mortality risk prediction. The primary objective was to improve prediction accuracy, cross-database robustness, and interpretability across heterogeneous surgical populations and institutions. Methods: We retrospectively analyzed 173,990 surgical cases from the INSPIRE (Informative Surgical Patient Dataset for Innovative Research Environment) and HUAXI databases. PRIME-MoE used 4 one-layer unidirectional long short-term memory experts with dense softmax routing based on static surgical context. We evaluated discrimination, calibration, threshold-specific operating points, parameter count, graphics processing unit inference latency, routing patterns, and a sensitivity analysis that truncated the final 30 minutes of each operation without retraining. Results: PRIME-MoE achieved internal-test area under the receiver operating characteristic curves (AUROCs) of 93.8 (95% CI 92.3‐96.0) in INSPIRE and 90.7 (95% CI 87.1‐94.8) in HUAXI. Reciprocal evaluation retained discrimination (AUROCs 90.8 and 87.8) but showed imperfect calibration (Brier scores 0.035‐0.049; calibration slopes 0.28‐0.49), supporting site-specific recalibration. Graphics processing unit inference required a median of 11.4 ms (9.1-18.0; 3.3-45.3) per case. Without retraining, scoring 30 minutes before the recorded end of surgery retained AUROCs of 93.1 in INSPIRE and 90.2 in HUAXI. Conclusions: PRIME-MoE provides an interpretable framework for postoperative in-hospital mortality prediction and retained discrimination in reciprocal evaluation across 2 heterogeneous perioperative databases. The 30-minute analysis supports near-end-of-surgery scoring, but calibration was insufficient for direct deployment. Prospective validation, local recalibration, threshold selection, and workflow evaluation are required before clinical use.

  • Top Cited Papers
    Open Access

    Development and Validation of a Dynamic Real-Time Risk Prediction Model for Intensive Care Units Patients Based on Longitudinal Irregular Data: Multicenter Retrospective Study

    by Zhuo Zheng, Jiawei Luo, Yingchao Zhu, Lei Du, Lan Lan, Xiaobo Zhou, Xiaoyan Yang, Shixin Huang

    Background: Timely and accurate prediction of short-term mortality is critical in intensive care units (ICUs), where patients’ conditions change rapidly. Traditional scoring systems, such as the Simplified Acute Physiology Score and Acute Physiology and Chronic Health Evaluation, rely on static variables collected within the first 24 hours of admission and do not account for continuously evolving clinical states. These systems lack real-time adaptability, interpretability, and generalizability. With the increasing availability of high-frequency electronic medical record (EMR) data, machine learning (ML) approaches have emerged as powerful tools to model complex temporal patterns and support dynamic clinical decision-making. However, existing models are often limited by their inability to handle irregular sampling and missing values, and many lack rigorous external validation across institutions. Objective: We aimed to develop a real-time, interpretable risk prediction model that continuously assesses ICU patient mortality using irregular, longitudinal EMR data, with improved performance and generalizability over traditional static scoring systems. Methods: A time-aware bidirectional attention-based long short-term memory (TBAL) model was developed using EMR data from the MIMIC-IV (Medical Information Mart for Intensive Care) and eICU Collaborative Research Database (eICU-CRD) databases, comprising 176,344 ICU stays. The model incorporated dynamic variables, including vital signs, laboratory results, and medication data, updated hourly, to perform static and continuous mortality risk assessments. External cross-validation and subgroup sensitivity analyses were conducted to evaluate robustness and fairness. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, and F1-score. Interpretability was enhanced using integrated gradients to identify key predictors. Results: For the static 12-hour to 1-day mortality prediction task, the TBAL model achieved AUROCs of 95.9 (95% CI 94.2-97.5) and 93.3 (95% CI 91.5-95.3) and AUPRCs of 48.5 and 21.6 in MIMIC-IV and eICU-CRD, respectively. Accuracy and F1-scores reached 94.1 and 46.7 in MIMIC-IV and 92.2 and 28.1 in eICU-CRD. In dynamic prediction tasks, AUROCs reached 93.6 (95% CI 93.2-93.9) and 91.9 (95% CI 91.6-92.1), with AUPRCs of 41.3 and 50, respectively. The model maintained high recall for positive cases (82.6% and 79.1% in MIMIC-IV and eICU-CRD). Cross-database validation yielded AUROCs of 81.3 and 76.1, confirming generalizability. Subgroup analysis showed stable performance across age, sex, and severity strata, with top predictors including lactate, vasopressor use, and Glasgow Coma Scale score. Conclusions: The TBAL model offers a robust, interpretable, and generalizable solution for dynamic real-time mortality risk prediction in ICU patients. Its ability to adapt to irregular temporal patterns and to provide hourly updated predictions positions it as a promising decision-support tool. Future work should validate its utility in prospective clinical trials and investigate its integration into real-world ICU workflows to enhance patient outcomes.


  • Open Access

    Development and Validation of a Dynamic Real-Time Risk Prediction Model for Intensive Care Units Patients Based on Longitudinal Irregular Data: Multicenter Retrospective Study (Preprint)

    by Zhuo Zheng, Jiawei Luo, Yingchao Zhu, Lei Du, Lan Lan, Xiaobo Zhou, Xiaoyan Yang, Shixin Huang

    BACKGROUND Timely and accurate prediction of short-term mortality is critical in intensive care units (ICUs), where patients’ conditions change rapidly. Traditional scoring systems, such as the Simplified Acute Physiology Score and Acute Physiology and Chronic Health Evaluation, rely on static variables collected within the first 24 hours of admission and do not account for continuously evolving clinical states. These systems lack real-time adaptability, interpretability, and generalizability. With the increasing availability of high-frequency electronic medical record (EMR) data, machine learning (ML) approaches have emerged as powerful tools to model complex temporal patterns and support dynamic clinical decision-making. However, existing models are often limited by their inability to handle irregular sampling and missing values, and many lack rigorous external validation across institutions. OBJECTIVE We aimed to develop a real-time, interpretable risk prediction model that continuously assesses ICU patient mortality using irregular, longitudinal EMR data, with improved performance and generalizability over traditional static scoring systems. METHODS A time-aware bidirectional attention-based long short-term memory (TBAL) model was developed using EMR data from the MIMIC-IV (Medical Information Mart for Intensive Care) and eICU Collaborative Research Database (eICU-CRD) databases, comprising 176,344 ICU stays. The model incorporated dynamic variables, including vital signs, laboratory results, and medication data, updated hourly, to perform static and continuous mortality risk assessments. External cross-validation and subgroup sensitivity analyses were conducted to evaluate robustness and fairness. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, and F1-score. Interpretability was enhanced using integrated gradients to identify key predictors. RESULTS For the static 12-hour to 1-day mortality prediction task, the TBAL model achieved AUROCs of 95.9 (95% CI 94.2-97.5) and 93.3 (95% CI 91.5-95.3) and AUPRCs of 48.5 and 21.6 in MIMIC-IV and eICU-CRD, respectively. Accuracy and F1-scores reached 94.1 and 46.7 in MIMIC-IV and 92.2 and 28.1 in eICU-CRD. In dynamic prediction tasks, AUROCs reached 93.6 (95% CI 93.2-93.9) and 91.9 (95% CI 91.6-92.1), with AUPRCs of 41.3 and 50, respectively. The model maintained high recall for positive cases (82.6% and 79.1% in MIMIC-IV and eICU-CRD). Cross-database validation yielded AUROCs of 81.3 and 76.1, confirming generalizability. Subgroup analysis showed stable performance across age, sex, and severity strata, with top predictors including lactate, vasopressor use, and Glasgow Coma Scale score. CONCLUSIONS The TBAL model offers a robust, interpretable, and generalizable solution for dynamic real-time mortality risk prediction in ICU patients. Its ability to adapt to irregular temporal patterns and to provide hourly updated predictions positions it as a promising decision-support tool. Future work should validate its utility in prospective clinical trials and investigate its integration into real-world ICU workflows to enhance patient outcomes. CLINICALTRIAL